Literature DB >> 1266895

Drug addiction in pregnancy and the neonate.

G Blinick, R C Wallach, E Jerez, B D Ackerman.   

Abstract

Drug addiction during pregnancy has been managed in two ways: the detoxification program and the methadone-maintenance treatment program. In the detoxification program, there have been few complications for the mother and child except for low birth weight, meconium-stained amniotic fluid, and an increase in breech presentation. The methadone-maintenance treatment program at this time is the most satisfactory approach to the treatment of heroin addiction. The complications of pregnancy in this program are similar to those of the average obstetric population. Low birth weight at term is still frequent for those on methadone maintenance. The problem of multiple drug abuse, including heroin, cocaine, alcohol, tranquilizers, and amphetamines, requires more attention. The characteristics of the withdrawal syndrome and its treatment in infants are described. Excessive weight loss and irritability are commin in these infants. Of the many drugs available for the treatment of the newborn withdrawal syndrome, diazepam is currently favored. The long-term effects of intrauterine drug exposure, the withdrawal syndrome, and treatment are generally unknown. Schedules for management of adult narcotic, alcohol, and barbiturate abuse and newborn narcotic withdrawal are suggested.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1266895     DOI: 10.1016/0002-9378(76)90583-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Treatment of Prescription Opioid Use Disorder in Pregnant Women.

Authors:  Constance Guille; Kelly S Barth; Julio Mateus; Jenna L McCauley; Kathleen T Brady
Journal:  Am J Psychiatry       Date:  2017-03-01       Impact factor: 18.112

2.  Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration.

Authors:  Allan J Barnes; Bertrand R Brunet; Robin E Choo; Patrick Mura; Rolley E Johnson; Hendrée E Jones; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2010-08       Impact factor: 3.681

3.  Protracted analgesia in young and adult rats maternally exposed to methadone.

Authors:  I S Zagon; P J McLaughlin
Journal:  Experientia       Date:  1980-03-15

4.  Neuronal cell deficits following exposure to methadone in rats.

Authors:  I S Zagon; P J McLaughlin
Journal:  Experientia       Date:  1982-10-15

5.  Methadone and brain development.

Authors:  I S Zagon; P J McLaughlin
Journal:  Experientia       Date:  1977-11-15

Review 6.  Methadone and buprenorphine for the management of opioid dependence in pregnancy.

Authors:  Hendrée E Jones; Loretta P Finnegan; Karol Kaltenbach
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

7.  Methadone and metabolites in hair of methadone-assisted pregnant women and their infants.

Authors:  Sarah K Himes; Robert S Goodwin; Colleen M Rock; Hendrée E Jones; Rolley E Johnson; Diana G Wilkins; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2012-06       Impact factor: 3.681

8.  Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment.

Authors:  Hendrée E Jones; Kevin E O'Grady; Michelle Tuten
Journal:  Am J Addict       Date:  2011-03-08

9.  Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.

Authors:  Alexander G Agthe; George R Kim; Kay B Mathias; Craig W Hendrix; Raul Chavez-Valdez; Lauren Jansson; Tamorah R Lewis; Myron Yaster; Estelle B Gauda
Journal:  Pediatrics       Date:  2009-04-27       Impact factor: 7.124

10.  Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.

Authors:  Uma M Reddy; Jonathan M Davis; Zhaoxia Ren; Michael F Greene
Journal:  Obstet Gynecol       Date:  2017-07       Impact factor: 7.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.